JPRN-UMIN000016947已完成未知
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug - Effect of the Integrated Approach to Symptom Management for skin toxicity associated with molecularly targeted drug
niversity of Hyogo0 个研究点目标入组 20 人开始时间: 2015年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who cannot communicate in Japanese and be described to understand the contents of the questionnaire.
研究者
相似试验
已完成
不适用
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapyhematological malignancies oral mucositis associated with cancer therapyJPRN-UMIN000016948niversity of Hyogo20
招募中
不适用
Examine the patient's response and symptom improvement using the intervention under the Integrated Approach to Symptom Management Model for the patients who has lymphedemalymphedema associated with cancer therapyJPRN-UMIN000014469niversity of Hyogo20
进行中（未招募）
不适用
Pain assessment in patients with Oral Lichen Planus and Burning Mouth Syndrome during the COVID-19 pandemicBurning Mouth Syndromeichen Planus, OralD008010K14.6RBR-62936mfFaculdade de Odontologia da Universidade de São Paulo
已完成
不适用
Evaluating the response to suspected disease outbreaks using a short message service (SMS) model14 priority diseases that require immediate reporting: adverse events following immunization, anthrax, cholera, Guinea worm, measles, neonatal tetanus, plague, Rift Valley fever, severe acute respiratory infections, viral hemorrhagic fever, yellow fever, and other (any public health event of national and international concerns).Infections and InfestationsISRCTN79529838agasaki University (Japan)153
招募中
2 期
Pathologic response, side-effects, and overall survival in cervical cancer under treatment with neo-adjuvant chemotherapy and surgerylocally advanced cervical cancer.Malignant neoplasm of cervix uteriIRCT2017090236033N1Vice-chancellery for Research of Mashhad University of Medicla Sciences30